Jim Simons
WINT

Jim Simons’s Windtree Therapeutics Inc WINT Stock Holding History

Jim Simons’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-19,891
Closed -$51K – 3626
2016
Q3 		$51K Sell
19,891
-13,100
-40% -$28.5K ﹤0.01% 3250
2016
Q2 		$64K Buy
32,991
+7,508
+29% +$18.1K ﹤0.01% 3213
2016
Q1 		$43K Buy
25,483
+24,433
+2,327% +$52.5K ﹤0.01% 3292
2015
Q4 		$3K Buy
+1,050
New +$4.31K ﹤0.01% 3251
2013
Q3 		– Sell
-885
Closed -$19K – 3044
2013
Q2 		$19K Buy
+885
New +$21.8K ﹤0.01% 2740

Other funds holding WINT

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Jim Simons's WINT Position: Q4 2016 in Review

Jim Simons sold out of Windtree Therapeutics Inc (WINT) in Q4 2016, closing a stake of 19,891 shares — an estimated $51K sold.

Jim Simons first reported a position in WINT in Q2 2013 and held it in 5 quarters. The position peaked at $64K in Q2 2016. 31 funds tracked by Wall St. Rank hold WINT as of Q4 2016.

  • Jim Simons reported no remaining Windtree Therapeutics Inc position as of Q4 2016 after selling out during the quarter.
  • Jim Simons sold 19,891 Windtree Therapeutics Inc shares in Q4 2016, an estimated $51K.
  • Jim Simons first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 5 quarters.
  • Jim Simons's Windtree Therapeutics Inc position peaked at $64K in Q2 2016.
  • 31 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q4 2016.

Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.